Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa

Nav

General Info

Email
Print

Geography

Angola (AGO)

Benin (BEN)

Botswana (BWA)

Burkina Faso (BFA)

Burundi (BDI)

Cameroon (CMR)

Central African Republic (CAF)

Chad (TCD)

Comoros (COM)

Congo (COG)

Côte d'Ivoire (CIV)

Democratic Republic of the Congo (COD)

Djibouti (DJI)

Equatorial Guinea (GNQ)

Eritrea (ERI)

Ethiopia (ETH)

Gabon (GAB)

Gambia (GMB)

Guinea (GIN)

Guinea-Bissau (GNB)

Kenya (KEN)

Liberia (LBR)

Madagascar (MDG)

Malawi (MWI)

Mali (MLI)

Mauritania (MRT)

Namibia (NAM)

Niger (NER)

Nigeria (NGA)

Rwanda (RWA)

Sao Tome and Principe (STP)

Senegal (SEN)

Sierra Leone (SLE)

Somalia (SOM)

South Sudan (SSD)

Sudan (SDN)

Togo (TGO)

Uganda (UGA)

United Republic of Tanzania (TZA)

Zambia (ZMB)

Zimbabwe (ZWE)

View all

Coverage type

Global

Time period covered

01/2013 - 12/2014

Data type

Scientific literature

Keywords

DALYs, Health care costs, Health care economics, Health care expenditures, Malaria, Prevalence, Preventive interventions, Vaccine preventable childhood diseases

Citation

Authors

Galactionova K, Tediosi F, Camponovo F, Smith TA, Gething PW, Penny MA

Journal

Vaccine

Volume

35

Issue

1

Pages

53-60

Publication year

2017

Suggested citation

Galactionova K, Tediosi F, Camponovo F, Smith TA, Gething PW, Penny MA. Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa. Vaccine. 2017; 35(1): 53-60.

DOI

10.1016/j.vaccine.2016.11.042

PMID

27890400

GHDx Entry last modified on: Apr 10, 2023